A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/28 (2006.01) A61K 9/16 (2006.01) A61K 9/50 (2006.01) A61P 25/24 (2006.01) A61K 31/137 (2006.01)
Patent
CA 2728193
There is described a pharmaceutical composition for controlled release of an active compound wherein the active compound is selected from the group comprising tramadol, resveratrol, acetaminophen, xorphanol, cinfenoac, furcloprofen, bismuth subsalicylate, enofelast, triflusal, ketorfanol, indriline, furofenac, cizolirtine, dacemazine, demelverine, and fenethazine, and derivatives and/or combinations thereof for the treatment or alleviation of depression. More particularly, there is described an abuse resistant pharmaceutical composition for the treatment of, inter alia, depression and controlled release pharmaceutical compositions of related thereto.
La présente invention concerne une composition pharmaceutique pour la libération contrôlée dun composé actif, celui-ci étant choisi dans le groupe comprenant le tramadol, le resvératrol, le paracétamol, le xorphanol, le cinfénoac, le furcloprofène, le subsalicylate de bismuth, lénofélast, le triflusal, le kétorfanol, lindriline, le furofénac, la cizolirtine, la dacémazine, la démelvérine et la fénéthazine, et des dérivés et/ou leurs combinaisons pour le traitement ou le soulagement de la dépression. De manière plus particulière, linvention concerne une composition pharmaceutique nentraînant pas dusage abusif pour le traitement, entre autres, de la dépression et des compositions pharmaceutiques à libération contrôlée qui y sont apparentées.
Idowu Olusola Clement
Mckeown Philip
Young Malcolm Philip
E-Therapeutics Plc
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Controlled release treatment of depression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release treatment of depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release treatment of depression will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1344138